Eibl N - Search Results

1

Risk stratification for renal transplantation after cardiac or lung transplantation: single-center experience and review of the literature.

Rosenberger C, Stein J, Jürgensen JS, Eibl N, Babel N, Bachmann U, Kemper D, Knosalla C, Hetzer R, Frei U, Lehmkuhl H, Reinke P. Rosenberger C, et al. Among authors: eibl n. Kidney Blood Press Res. 2007;30(4):260-6. doi: 10.1159/000104867. Epub 2007 Jun 29. Kidney Blood Press Res. 2007. PMID: 17622737 Review.

2

Treatment of cytomegalovirus disease with valganciclovir in renal transplant recipients: a single center experience.

Babel N, Gabdrakhmanova L, Juergensen JS, Eibl N, Hoerstrup J, Hammer M, Rosenberger C, Hoeflich C, Frei U, Rohde F, Volk HD, Reinke P. Babel N, et al. Among authors: eibl n. Transplantation. 2004 Jul 27;78(2):283-5. doi: 10.1097/01.tp.0000128343.88355.14. Transplantation. 2004. PMID: 15280691

3

Development of Kaposi's sarcoma under sirolimus-based immunosuppression and successful treatment with imiquimod.

Babel N, Eibl N, Ulrich C, Bold G, Sefrin A, Hammer MH, Rosenberger C, Reinke P. Babel N, et al. Among authors: eibl n. Transpl Infect Dis. 2008 Feb;10(1):59-62. doi: 10.1111/j.1399-3062.2007.00239.x. Epub 2007 Apr 11. Transpl Infect Dis. 2008. PMID: 17428275

4

Gitelman syndrome.

Roser M, Eibl N, Eisenhaber B, Seringer J, Nagel M, Nagorka S, Luft FC, Frei U, Gollasch M. Roser M, et al. Among authors: eibl n. Hypertension. 2009 Jun;53(6):893-7. doi: 10.1161/HYPERTENSIONAHA.108.127993. Epub 2009 Apr 6. Hypertension. 2009. PMID: 19349556 No abstract available.

5

Arteriovenous malformation in a kidney allograft.

Eibl N, Rudolph B, Roser M, Kahl A, Mihatsch MJ, Gollasch M. Eibl N, et al. NDT Plus. 2009 Aug;2(4):320-2. doi: 10.1093/ndtplus/sfp036. Epub 2009 Apr 15. NDT Plus. 2009. PMID: 25984027 Free PMC article. No abstract available.

6

Improved metabolic control decreases platelet activation markers in patients with type-2 diabetes.

Eibl N, Krugluger W, Streit G, Schrattbauer K, Hopmeier P, Schernthaner G. Eibl N, et al. Eur J Clin Invest. 2004 Mar;34(3):205-9. doi: 10.1111/j.1365-2362.2004.01320.x. Eur J Clin Invest. 2004. PMID: 15025679

7

Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells.

Spatz M, Eibl N, Hink S, Wolf HM, Fischer GF, Mayr WR, Schernthaner G, Eibl MM. Spatz M, et al. Among authors: eibl n. Cell Immunol. 2003 Jan;221(1):15-26. doi: 10.1016/s0008-8749(03)00043-1. Cell Immunol. 2003. PMID: 12742378

8

Impaired primary immune response in type-1 diabetes: results from a controlled vaccination study.

Eibl N, Spatz M, Fischer GF, Mayr WR, Samstag A, Wolf HM, Schernthaner G, Eibl MM. Eibl N, et al. Clin Immunol. 2002 Jun;103(3 Pt 1):249-59. doi: 10.1006/clim.2002.5220. Clin Immunol. 2002. PMID: 12173299 Clinical Trial.

9

Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha.

Eibl N, Gschwantler M, Ferenci P, Eibl MM, Weiss W, Schernthaner G. Eibl N, et al. Eur J Gastroenterol Hepatol. 2001 Mar;13(3):295-8. doi: 10.1097/00042737-200103000-00015. Eur J Gastroenterol Hepatol. 2001. PMID: 11293453

10

Magnesium supplementation in type 2 diabetes.

Eibl N, Schnack C, Schernthaner G. Eibl N, et al. Diabetes Care. 1998 Nov;21(11):2031-2. doi: 10.2337/diacare.21.11.2031. Diabetes Care. 1998. PMID: 9802766 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page